Autoregulation of cholesterol synthesis: physiologic and pathophysiologic consequences.

Area of Science:

• Biochemistry
• Developmental Biology
• Reproductive Biology

Background:

• Cholesterol synthesis is tightly regulated through 19 metabolic steps from lanosterol to cholesterol.
• Tissue-specific synchronization of synthesis rates is the general paradigm.
• Ovarian exceptions exist, notably the role of FF-MAS (follicular fluid meiosis activating sterol) in oocyte maturation.

Purpose of the Study:

• To explore the role of sterol intermediates and oxysterol metabolites in physiological and pathophysiological processes.
• To investigate the implications of mutations affecting cholesterol synthesis synchronization.
• To understand the link between dysregulated sterol metabolism and developmental abnormalities.

Main Methods:

• Review of existing literature on cholesterol synthesis pathways.
• Analysis of genetic mutations impacting sterol metabolism synchronization.
• Examination of experimental animal models demonstrating the effects of oxysterol metabolites.

Main Results:

• FF-MAS (follicular fluid meiosis activating sterol) in the ovary locally increases to activate oocyte maturation, deviating from systemic synchronization.
• Mutations disrupting synchronization lead to increased sterol intermediates that are shunted to an alternate oxysterol metabolic pathway.
• Animal models suggest oxysterol metabolites are key factors in the dysmorphism observed in fetal development associated with these genetic diseases.

Conclusions:

• Sterol intermediates, particularly novel oxysterol metabolites, may play a broader, underappreciated role in both normal physiology and disease.
• Understanding these alternate pathways is crucial for comprehending developmental disorders and potentially other pathophysiological conditions.
• The ovary serves as a key example of localized regulation within the broader cholesterol synthesis network.